The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Shah
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 5.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Niraj Rajnikant Shah, a non-promoter investor based in Mumbai, has acquired 5,47,000 shares of Speciality Medicines Ltd through open market purchases. The acquisition took place between March 30, 2026 and May 14, 2026, taking his holding from 0% to 6.22% of the company's total share capital. The total equity capital of the company stands at Rs. 8.78 crore divided into 87,85,796 shares of Rs. 10 each. This disclosure is required under SEBI SAST regulations because crossing the 5% shareholding threshold triggers mandatory disclosure to stock exchanges.
The acquisition of a 6.22% stake by a non-promoter in the open market may indicate bullish sentiment from a significant investor, though this holding is still well below the 25% threshold that would trigger an open offer obligation under SAST regulations.